Longevity medicine
Risk assessment, systems-based thinking, biomarkers, patient selection and evidence-based longevity frameworks
Australia’s clinic-ready longevity certification
Join the Founding Cohort: Certification in Longevity Medicine
A live education program for practitioners ready to deepen their capability in longevity and regenerative medicine.
Presented by Biogenix · Powered by MedBridge Global of Australia
Presented by Biogenix and powered by MedBridge Global, this practitioner program brings together clinical education, emerging science and practical implementation across longevity and regenerative medicine.
Starting Tuesday 3 November 2026, you will be led through weekly sessions by faculty leads Dr Dominik Schaffner and Dr Baback Amen, joined by expert faculty across longevity, regenerative medicine, clinical implementation and practice operations.
The program
A structured four-week learning experience
For appropriately qualified healthcare practitioners seeking a practical, evidence-based framework for modern longevity and regenerative medicine.
Designed for clinicians who want a coherent framework for responsible integration.
Each week includes
- Two one-hour live, faculty-led sessions, with each recording available 24/7 straight afterwards
- Live faculty teaching, interactive clinical discussion and self-guided learning
- A focus on evidence, safety, documentation, implementation and responsible clinical decision-making
- Protocol frameworks, documentation and implementation tools
- Demonstrations and case-based learning
- Practice-readiness guidance, team workflow and patient-journey considerations, with optional operational support beyond the classroom
- Specialty-relevant application for orthopaedics, IV therapy, chiropractic and podiatry
What we will cover
Regenerative medicine in orthopaedics
Orthobiologics, musculoskeletal evaluation, patient selection, evidence, risk and multidisciplinary care pathways
IV therapy
Clinical frameworks, safety, documentation, protocols and practice implementation considerations
Peptide therapy
Mechanisms, evidence, patient selection, clinical governance and responsible practice considerations
Hormone medicine
Assessment frameworks, foundational principles, monitoring and clinical decision-making
Stem-cell and extracellular-vesicle science
Biology, current evidence, safety, ethics, regulatory context and responsible communication
Red-light and photobiomodulation
Mechanisms, evidence appraisal, application frameworks and treatment-planning considerations. A self-guided module supported by a recorded expert webinar.
Specialty application tracks
Chiropractic, podiatric and multidisciplinary applications within professional scope and local requirements
Learn from clinical leaders
Faculty lead
Dr Dominik Schaffner
CEO and Medical Director, Biogenix
Faculty lead
Dr Baback Amen
Medical Director, MedBridge Global
Plus expert faculty across longevity, regenerative medicine, clinical implementation and practice operations.
Beyond the curriculum
Participants also learn how to build a profitable practice, grounded in straightforward, implementable models. Your certification experience includes access to selected practice-readiness resources and partner-led, non-CPD educational demonstrations, including:
- Professional indemnity insurance education and risk-management considerations
- EMR workflow demonstrations for documentation, care coordination and operational implementation
- Practice protocols, consent and documentation frameworks
- Patient-journey mapping and staff competency planning for pricing models, and TGA-appropriate communication tools for use with patients and prospective patients
- Optional implementation, consulting and in-person coaching pathways
Partner demonstrations, products, software and consulting services are separate from the CPD-eligible educational activity. Participation in or purchase of any partner service is not required for certification completion.
Bonus · two weeks after the program
The Business Side of Longevity Medicine in Australia
With Serena Brock, CEO + Founder, MedBridge Global
Two optional weeks on putting it into practice: the business and communication side of running longevity medicine in an Australian clinic. Open to every participant, and not required for certification.
Certification pathway
Participants who complete the required learning activities and assessment receive the Certification in Longevity Medicine.
CPD participation documentation
Details of eligible learning hours and supporting CPD documentation will be provided for practitioner self-recording through your own CPD home, where applicable. Acceptance remains subject to each learner’s profession, registration requirements and CPD home.
Who should attend
Appropriately qualified and registered healthcare practitioners seeking to build deeper capability in longevity, regenerative and integrative clinical practice, including:
- GPs and medical practitioners
- Specialists, including dermatologists, plastic surgeons, orthopaedic surgeons and sport and exercise physicians
- Nurse practitioners and registered nurses, where permitted
- Pharmacists and dentists
- Chiropractors, podiatrists and physiotherapists
- Dietitians, psychologists and other allied health professionals working within their professional scope
Prescribing and administration of any therapy remain within each practitioner’s professional scope and applicable Australian regulations.
Enrolment now open
Join the founding cohort helping shape the future of longevity medicine in Australia, and earn the Certification in Longevity Medicine.
- 3–30 November 2026
- Four weeks
- Live online
- Australia-customised sessions
The four-week certification, including the bonus business module. Pay in full or in three monthly instalments.
Pay in full$2,499 AUD + $249 GSTOne paymentEnrol nowInstalment plan$833 AUD / month + $83 GSTThree monthly paymentsEnrol now
Founding cohort places are limited to 50 practitioners.
For enrolment, group-practice packages and program information:
[email protected]
WhatsApp +1 (704) 620-9797
This communication is intended for registered healthcare practitioners and their teams. It is professional education, not advertising, and does not promote, recommend or offer to supply any therapeutic good. It is not intended for members of the public.
This educational program does not replace individual clinical judgement, regulatory obligations, product instructions for use, or legal advice. It does not authorise participants to provide treatments outside their professional scope or applicable law. Content addressing stem cells, extracellular vesicles/exosomes, peptides and other emerging therapies is educational and must not be interpreted as a representation that any product or procedure is approved, available, appropriate or lawful for any particular patient or indication in Australia.